IRIS - Res&Arch Institutional Research Information System - Research & Archive

PORCELLATI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.730
EU - Europa 2.928
AS - Asia 2.758
SA - Sud America 463
Continente sconosciuto - Info sul continente non disponibili 243
AF - Africa 61
OC - Oceania 20
Totale 11.203
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.556
SG - Singapore 1.319
IT - Italia 522
CN - Cina 412
IE - Irlanda 389
RU - Federazione Russa 377
BR - Brasile 355
SE - Svezia 349
UA - Ucraina 321
HK - Hong Kong 296
VN - Vietnam 269
DE - Germania 243
FR - Francia 184
FI - Finlandia 155
GB - Regno Unito 130
BD - Bangladesh 98
IN - India 75
CA - Canada 73
ES - Italia 70
KR - Corea 58
TR - Turchia 38
AT - Austria 37
MX - Messico 36
PL - Polonia 36
AR - Argentina 33
ZA - Sudafrica 31
IQ - Iraq 27
JP - Giappone 27
NL - Olanda 26
UZ - Uzbekistan 23
PK - Pakistan 20
CO - Colombia 19
CZ - Repubblica Ceca 19
AU - Australia 17
VE - Venezuela 17
TT - Trinidad e Tobago 15
ID - Indonesia 14
PH - Filippine 14
SA - Arabia Saudita 14
BE - Belgio 13
CH - Svizzera 12
EC - Ecuador 12
JM - Giamaica 10
PE - Perù 9
CR - Costa Rica 8
GT - Guatemala 7
RO - Romania 7
AZ - Azerbaigian 6
BO - Bolivia 6
CW - ???statistics.table.value.countryCode.CW??? 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
MY - Malesia 6
EG - Egitto 5
KE - Kenya 5
NP - Nepal 5
SV - El Salvador 5
DK - Danimarca 4
EE - Estonia 4
GR - Grecia 4
IL - Israele 4
OM - Oman 4
PS - Palestinian Territory 4
PY - Paraguay 4
UY - Uruguay 4
BB - Barbados 3
CL - Cile 3
DO - Repubblica Dominicana 3
EU - Europa 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
BW - Botswana 2
GE - Georgia 2
HN - Honduras 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
GP - Guadalupe 1
HR - Croazia 1
HT - Haiti 1
IM - Isola di Man 1
KG - Kirghizistan 1
Totale 10.955
Salva come PNG Salva come JPEG
Città #
Singapore 954
San Jose 516
Chandler 474
Dublin 390
Ashburn 385
Hong Kong 293
San Mateo 224
Boardman 177
Santa Clara 177
Jacksonville 161
Council Bluffs 149
Moscow 129
Princeton 113
Altamura 112
Medford 110
Beijing 104
Lauterbourg 103
Munich 93
Perugia 92
Wilmington 92
New York 87
Lawrence 80
Ann Arbor 79
Los Angeles 78
Dong Ket 76
Seoul 58
Ho Chi Minh City 54
Andover 53
Rome 53
Helsinki 52
Valencia 50
The Dalles 42
Des Moines 40
Hanoi 37
Frankfurt am Main 33
Chicago 30
Brooklyn 29
São Paulo 29
Dallas 28
Saint Petersburg 27
Milan 25
Piscataway 25
Woodbridge 23
Warsaw 22
Norwalk 21
Nuremberg 21
Falls Church 20
Orem 20
Phoenix 20
Tokyo 20
Turku 20
North Bergen 19
Toronto 19
Amsterdam 16
Denver 16
Tashkent 16
Vienna 16
Amelia 15
Atlanta 14
Brno 14
London 14
San Francisco 14
Stockholm 14
Izmir 13
Montreal 13
Baghdad 12
Brussels 12
Da Nang 12
Falkenstein 12
Houston 12
Mumbai 11
Johannesburg 10
Shanghai 10
Ankara 9
Boston 9
Foligno 9
Istanbul 9
Mexico City 9
Poplar 9
Porto Alegre 9
Belo Horizonte 8
Bexley 8
Brasília 8
Buffalo 8
Charlotte 8
Columbus 8
Dhaka 8
Florence 8
Newark 8
Rio de Janeiro 8
San Paolo di Civitate 8
Auburn Hills 7
Chaguanas 7
Guayaquil 7
Hải Dương 7
Melbourne 7
Redmond 7
Riyadh 7
Curitiba 6
Durban 6
Totale 6.616
Salva come PNG Salva come JPEG
Nome #
Ipoglicemia da iperinsulinismo organico: un caso di nesidioblastosi dell’adulto. 221
Adrenaline vs glucagon in the primacy of glucose counterregulation 181
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 172
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 168
Hypoglycemia 158
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 152
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 144
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 141
EFFECT OF PYRIDOXAL 5'-PHOSPHATE AND VALPROICACID ON PHOSPHOLIPID SYNTHESIS INNEUROBLASTOMA NA 140
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study 139
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 138
Awareness, identification and prevention of insulin injection-associated lipodystrophies 138
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 132
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 131
A novel surrogate index for hepatic insulin resistance. 131
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 130
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 129
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 129
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 128
Cognitive function in hypoglycaemia 124
Ipoglicemia: implicazioni cliniche e impatto sulla salute 122
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 121
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 118
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 117
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 117
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 116
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 114
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 113
[Usefulness of plantar pressure measurement for the prevention and treatment of neuropathic diabetic foot]. 113
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 112
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 110
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 109
Alternate splicing in human Na+-MI cotransporter gene yelds differentially regulated trasport isoforms 108
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 107
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 106
EPIDEMIOLOGICAL SURVEY FOR THE DETECTION OF NON–TRAUMATIC LOWER EXTREMITY AMPUTATIONS IN DIABETIC PATIENTS IN THE UMBRIA REGION (ITALY). 105
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 105
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 104
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 103
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes. 103
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 103
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 102
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 102
Body composition and common carotid artery remodeling in a healthy population 101
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 100
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 99
Glucagon: the effects of its excess and deficiency on insulin action 98
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 98
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 96
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 95
The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study 94
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 94
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 94
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 94
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 93
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? 93
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 92
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 90
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 89
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 89
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 87
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 87
Obesity and carotid artery remodeling 87
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 86
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 81
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 81
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 80
Responses to hypoglycemia in diabetic autonomic neuropathy. 80
Insulin therapy and hypoglycemia: the size of the problem 78
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 78
Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. 77
Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: The single point insulin sensitivity estimator (SPISE) 77
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 76
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 76
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. 76
Recovery and prevention of hypoglycaemia unawareness in Type 1 diabetes mellitus 76
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. 75
Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: a Double-Blind, Randomized, Crossover Study. Response to Banarer. 75
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women 75
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways 74
Gli Analoghi dell’Insulina ad Azione Ritardo: dalla storia di ieri alle opzioni di oggi 73
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 72
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 71
Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial 70
The physiological basis of insulin therapy in people with diabetes mellitus 70
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 70
Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials 69
L’insulina biosimilare è “clinicamente uguale” all’originator, ma… 68
Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort 68
How to accurately establish pharmacokinetics/ pharmacodynamics of long- Acting insulins in humans: Relevance to biosimilar insulins 67
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology 67
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes mellitus. 66
INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS IS DIFFERENT BETWEEN GLUCOSE AND PROTEIN METABOLISM 66
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults 66
The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime? 65
Metabolic effects of an SGLT2 inhibitor (Dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes. Diabetes care 2020;43:2128– 2136 64
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs 64
Pharmacokinetics and pharmacodynamics of basal insulins. 62
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity 62
Ipoglicemia: Implicazioni cliniche e impatto sulla salute 62
Totale 9.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022642 0 0 0 59 20 14 8 271 17 25 102 126
2022/20231.510 116 287 17 126 115 191 2 69 527 6 43 11
2023/2024658 36 76 35 11 5 7 121 2 44 28 147 146
2024/20251.624 25 157 45 98 264 37 61 146 319 108 214 150
2025/20263.761 262 228 187 359 506 267 691 215 519 300 123 104
2026/20271.249 129 117 240 763 0 0 0 0 0 0 0 0
Totale 11.203